Solís-Olivares CA

Language: Spanish
References: 13
Page: 26-31
PDF size: 288.48 Kb.

ABSTRACT

Protein C and S deficiencies are considered part of the group of primary thrombophilia and merit long-term anticoagulant therapy, with the risk inherent thromboembolic events for patients. We report the case of a female patient 51 years old who carry the thrombophilia, obese, with lower limb venous insufficiency, type 2 diabetes and hypertension, which 10 years ago presented a severe episode of pulmonary thromboembolism, standing from then a permanent filter in the inferior cava vein and continuing indefinitely with anticoagulant therapy. She arrived at the hospital on this occasion by presenting a severe substernal pain oppressive type and sweating more severe dysnea in the clinical setting of a hypertensive crisis. The INR on admission was reported in 2.55. His electrocardiogram and chest radiograph were normal. Cardiac enzymes, color Doppler ultrasound of the lower limbs and color Doppler echocardiography reported no significant abnormalities. Finally, a CT angiography showed a thrombus in one of the segmental branch of the upper right pulmonary artery, discharged asymptomatic form the hospital, after five days. Although the guidelines have not established a recommendation for use indefinitely permanent filter in the inferior cava vein associated with anticoagulant therapy, in patients with clinical risk profiles so unique, it is possible synergistic benefit primarily to prevent recurrent episodes of thromboembolism massive pulmonary.

REFERENCES

1. Grassi CJ, Swan TL, Cardella JF et al. Quality improvement guidelines for percutaneous permanent inferior vena cava filter placement for the prevention of pulmonary embolism. J Vasc Interv Radiol. 2003; 14: S271-S275.

2. Torbicky A, Chairperson P, Perrier A et al. Guidelines on the diagnosis and management of acute pulmonary embolism. The task force for the diagnosis and management of acute pulmonary embolism of the european society of cardiology (ESC). European Heart Journal. 2008; 29: 2276-2315.

3. Kearon C, Akl EA, Comerota AJ et al. Antithrombotic therapy for VTE disease: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians. Evidence-based clinical practice guidelines. Chest. 2012; 141 (Suppl. 2): e419S-e494S.

4. Hammond CJ, Bakshi DR, Currie RJ et al. Audit of the use of IVC filters in the UK: experience from three centres over 12 years. Clin Radiol. 2009; 64: 502-510.

5. Raskob GE, Silverstein R, Bratzler BW, Heit JA, White RH. Surveillance for deep vein thrombosis and pulmonary embolism recommendations from a national workshop. Am J Prev Med. 2010; 38 (4S): S502-S509.

6. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the international cooperative pulmonary embolism registry (ICOPER). Lancet. 1999; 353: 1386-1389.

7. Ríos JL, Vargas CA. Filtros en vena cava inferior. Acta Médica Grupo Ángeles. 2006; 4 (2): 93-99.

8. The PREPIC Study Group. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism the PREPIC (prévention du risque d’embolie pulmonaire par interruption cave) randomized study. Circulation. 2005; 112: 416-422.

9. Sarosiek S, Crowther M, Sloan MJ. Indications, complications, and management of inferior vena cava filters: the experience in 952 patients at an academic hospital with a level I Trauma Center. JAMA Intern Med. 2013; 173 (7): 513-517.

10. Zamora Y, Agramonte OM, Rodríguez L. Deficiencia de proteínas C y S: marcadores de riesgo trombótico. Rev Cubana Hematol Inmunol Hemoter. 2013; 29 (1): 40-47.

11. Sohn CB, Lee SW, Kim SH. Inferior vena cava filter thrombosis in protein-S deficiency patient due to withdrawal of anticoagulation therapy after operation. J Med Cases. 2013; 4 (9): 612-615.

12. Hayduk B, Tomkowski WZ, Malek G, Davidson BL. Vena cava filter occlusion and venous thromboembolism risk in persistently anticoagulated patients a prospective, observational cohort study. Chest. 2010; 137 (4): 877-882.

13. Usoh F, Hingorani A, Ascher E et al. Long-term follow-up for superior vena cava filter placement. Ann Vasc Surg. 2009; 23 (3): 350-354.